2025-12-31 - Analysis Report
Okay, here's a breakdown of the Air Products and Chemicals Inc. (APD) stock analysis based on the provided information.

**0) Report Structure:**

*   **Simple Numbers First:** Each section presents the raw data.
*   **Simple Analysis:** Each section follows with a basic interpretation of the data.
*   **Comprehensive Summary:** Combines insights from all sections.

**1) Return Rate Comparison:**

*   **Ticker:** APD
*   **Company:** Air Products and Chemicals Inc. (Provides industrial gases and related equipment and services globally.)
*   **APD Cumulative Return:** -7.84%
*   **S&P 500 (VOO) Cumulative Return:** 102.21%
*   **Divergence:** -111.6 (Relative Divergence: 2.5)

**Analysis:** APD has significantly underperformed the S&P 500 over the period. The divergence is substantial, indicating a large difference in returns. The relative divergence of 2.5 suggests this performance is near the lowest end of its historical range compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year      | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
| --------- | ------- | ------- | ------- | ----- | ------ |
| 2015-2017 | 24.0%   | 64.6%   | -4.0%   | 0.1   | 36.5   |
| 2016-2018 | 21.0%   | 69.5%   | 6.0%    | 0.2   | 35.6   |
| 2017-2019 | 39.0%   | 69.9%   | 17.0%   | 0.7   | 52.3   |
| 2018-2020 | 21.0%   | 77.7%   | -3.0%   | 0.6   | 60.8   |
| 2019-2021 | 45.0%   | 77.7%   | -2.0%   | 0.7   | 67.7   |
| 2020-2022 | 6.0%    | 79.4%   | 7.0%    | 0.8   | 68.6   |
| 2021-2023 | -27.0%  | 79.4%   | -29.0%  | 0.8   | 61.0   |
| 2022-2024 | -39.0%  | 79.4%   | -59.0%  | 0.9   | 64.6   |
| 2023-2025 | -64.0%  | 74.8%   | -131.0% | 2.3   | 55.4   |

*   **CAGR (Compound Annual Growth Rate):** Fluctuates significantly, with recent periods showing substantial negative growth.
*   **MDD (Maximum Drawdown):** Consistently high, indicating significant risk of losses.
*   **Alpha:** Generally negative, especially in recent years, suggesting APD is underperforming relative to its risk (Beta).  The large negative Alpha in 2023-2025 is particularly concerning.
*   **Beta:** Trending upwards, indicating APD's volatility is increasing relative to the market. A Beta of 2.3 in the latest period is very high.
*   **Cap(B) (Capitalization in Billions):** Shows changes in company size over the years.

**2) Recent Stock Price Fluctuations:**

*   **Close:** 248.82
*   **Last Market Data:** Price: 248.82, Previous Close: 247.85, Change: 0.39
*   **5-day SMA:** 246.94
*   **20-day SMA:** 246.488
*   **60-day SMA:** 252.5995

**Analysis:** The stock price is currently above its 5-day and 20-day SMAs, which suggests a short-term upward trend.  However, it's below the 60-day SMA, indicating a potential longer-term downtrend. The small positive change from the previous close suggests some stabilization, but it's not a strong signal.

**3) Index Indicators:**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 73.83 (Approaching overbought territory)
*   **PPO:** 0.37
*   **Hybrid Signal:** "cash\_0% Buy 100% of cash (4 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)"
*   **Recent (20 days) relative divergence change:** -1.7 (Negative - Short-term decline)
*   **Expected Return (%):** -1285.5% (Very Negative - Expected underperformance vs. S&P 500)

**Analysis:**

*   **MRI:** Conflicting; while the MRI suggests high investment, other indicators are worrisome. The MRI score might be lagging or based on different factors not fully captured by other metrics.
*   **RSI:** The RSI suggests the stock may be overbought, potentially indicating a pullback is likely.
*   **PPO:** A positive PPO suggests that the shorter-term moving average is above the longer-term moving average.
*   **Hybrid Signal:** The Hybrid Signal recommends buying, but this contradicts the negative divergence change and the very low expected return.
*   **Relative Divergence Change:** The negative change in relative divergence confirms the short-term downward trend.
*   **Expected Return:** The significantly negative expected return is a major red flag, suggesting a high probability of continued underperformance.

**4) Recent News & Significant Events:**

*   **Mixed Analyst Moves:** Analyst sentiment is divided, indicating uncertainty about the stock's future.
*   **Shares Sold by Burney Co.:** A significant holder reducing their position can be a negative signal.
*   **25% Drop:** Indicates significant price volatility and recent struggles.
*   **Investor Alert (Pomerantz Law Firm Investigation):** A law firm investigation is a serious concern, potentially suggesting issues with the company's disclosures or business practices.
*   **Top Decliner Among S&P 500:** Highlights APD's recent underperformance within the broader market.
*   **Liquidity Mapping:** Focuses on potential price levels based on order book analysis, useful for short-term trading but less so for long-term investment decisions.

**Analysis:** The news headlines paint a negative picture. The combination of analyst uncertainty, share sales, a significant price drop, and a law firm investigation raises significant concerns.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean: 2.13)
*   **Target Price:** Average: $292.86, High: $340.00, Low: $245.00

**Analysis:** While the analyst consensus is a "Buy," it's crucial to consider the context of the negative news and financial indicators. The target price range is wide, indicating disagreement among analysts. The low target price is already below the current price. The lack of recent rating changes suggests analysts might be slow to react to recent negative developments.

**5) Recent Earnings Analysis:**

| 날짜       | EPS    | 매출     |
| ----------- | ------ | -------- |
| 2025-07-31 | 3.20   | 3.02 B$  |
| 2025-05-01 | -7.77  | 2.92 B$  |
| 2025-02-06 | 2.77   | 2.93 B$  |
| 2024-08-01 | 3.13   | 2.99 B$  |
| 2025-07-31 | 3.13   | 2.99 B$  |

**Analysis:**  The earnings picture is mixed. There is one significant negative EPS which likely contributed to stock weakness.  Revenue is relatively stable, but not showing substantial growth.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
| ---------- | -------- | ------------- |
| 2025-09-30 | $3.17B  | 32.25%        |
| 2025-06-30 | $3.02B  | 32.51%        |
| 2025-03-31 | $2.92B  | 29.57%        |
| 2024-12-31 | $2.93B  | 31.21%        |
| 2024-09-30 | $3.19B  | 33.98%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE      |
| ---------- | --------- | -------- |
| 2025-09-30 | $15.02B  | 0.03%    |
| 2025-06-30 | $15.54B  | 4.59%    |
| 2025-03-31 | $14.70B  | -11.77%   |
| 2024-12-31 | $16.69B  | 3.70%    |
| 2024-09-30 | $17.04B  | 11.45%   |

**Analysis:**

*   **Revenue & Profit Margin:** Revenue shows some fluctuation but is generally stable. Profit margins are relatively healthy but have decreased slightly from their peak.
*   **Equity & ROE:** Equity has generally decreased over the past year. The ROE (Return on Equity) shows significant volatility, with one quarter showing a large negative value. The most recent ROE is near zero, indicating very poor profitability relative to shareholder equity.

**7) Comprehensive Analysis (Summary):**

*   **Underperformance:** APD has significantly underperformed the S&P 500, and its recent performance is near the lowest end of its historical range relative to the market.
*   **Increased Risk:** Beta has been trending up, indicating higher market correlation.
*   **Negative Alpha:** Negative Alpha, especially in recent periods, indicating APD is underperforming relative to its risk (Beta).
*   **Negative Expected Return:** The significantly negative expected return indicates a high probability of continued underperformance.
*   **Mixed Indicators:** While the MRI is relatively high and the analyst consensus is "Buy," these are outweighed by negative factors.
*   **Negative News:** Recent news headlines are predominantly negative, including share sales, a significant price drop, analyst uncertainty, and a law firm investigation.
*   **Volatile ROE:** ROE showing significant volatility, with one quarter showing a large negative value, and the most recent quarter close to zero.
*   **Short-Term Rebound?** Stock price is above the 5-day and 20-day SMAs, which suggests a short-term upward trend.

**Overall Recommendation:** Based on the totality of the information, **a cautious approach is warranted.** While the analyst consensus and MRI might suggest a buy, the negative divergence, negative expected return, negative news, and volatile ROE outweigh these positive indicators. The investigation by a law firm should be taken seriously and indicates a high level of risk. The recent short-term trend should be taken into account.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.